This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: 1042 ABTL0812, a Dual Inhibitor of mTOR and Dihydrofolate Reductase With High Oral Efficacy and Safety Margin in Human Lung and Pancreatic Cancer Xenograft in Mice, European Journal of Cancer, July 2012, Elsevier,
DOI: 10.1016/s0959-8049(12)71653-2.
You can read the full text:
The following have contributed to this page
